RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+10.77%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$4.58B
AUM Growth
+$4.58B
(-2.1%)
Cap. Flow
+$43.2M
Cap. Flow
% of AUM
0.94%
Top 10 Holdings %
Top 10 Hldgs %
23.53%
Holding
172
New
18
Increased
60
Reduced
32
Closed
20
Top Buys
| 1 |
Immunocore
IMCR
|
$97.6M |
| 2 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$73M |
| 3 |
Bolt Biotherapeutics
BOLT
|
$51.3M |
| 4 |
Cullinan Oncology
CGEM
|
$44.8M |
| 5 |
AstraZeneca
AZN
|
$32.3M |
Top Sells
| 1 |
Neurocrine Biosciences
NBIX
|
$54.5M |
| 2 |
UnitedHealth
UNH
|
$48.4M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$47.9M |
| 4 |
Centene
CNC
|
$43.8M |
| 5 |
Immunovant
IMVT
|
$41.2M |
Sector Composition
| 1 | Healthcare | 93.74% |
| 2 | Consumer Staples | 1.75% |
| 3 | Industrials | 0.62% |
| 4 | Financials | 0.12% |
| 5 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Madrigal Pharmaceuticals
MDGL
$9.76B
| $30.2M | 0.66% | 258,500 +1,732 | +0.7% | +$203K |
|
52
Ascendis Pharma
ASND
$11.8B
| $30.1M | 0.66% | 233,500 | – | – |
|
53
Mirum Pharmaceuticals
MIRM
$3.71B
| $29.8M | 0.65% | 1,502,800 +6,275 | +0.4% | +$124K |
|
54
Evolent Health
EVH
$1.12B
| $29.2M | 0.64% | +1,445,000 | New | +$29.2M |
|
55
Prothena Corp
PRTA
$441M
| $29.1M | 0.63% | 1,156,900 +15,800 | +1% | +$397K |
|
|
SWAV
56
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $28.7M | 0.63% | 220,000 | – | – |
|
|
ACCD
57
DELISTED
Accolade, Inc. Common Stock
ACCD
| $28.4M | 0.62% | 625,000 +125,000 | +25% | +$5.67M |
|
58
Acadia Pharmaceuticals
ACAD
$4.38B
| $27.8M | 0.61% | 1,076,200 -536,300 | -33% | -$13.8M |
|
59
Pulmonx
LUNG
$69.7M
| $27.1M | 0.59% | 592,500 +92,500 | +19% | +$4.23M |
|
|
SPRB
60
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
| $26.2M | 0.57% | 1,579,301 -51,699 | -3% | -$858K |
|
61
Adaptive Biotechnologies
ADPT
$2.01B
| $26.2M | 0.57% | 650,000 +15,000 | +2% | +$604K |
|
|
AMRN
62
Amarin Corp
AMRN
$311M
| $26.1M | 0.57% | 4,195,000 | – | – |
|
|
PPD
63
DELISTED
PPD, Inc. Common Stock
PPD
| $25.5M | 0.56% | 675,000 +150,000 | +29% | +$5.68M |
|
64
Sarepta Therapeutics
SRPT
$1.78B
| $24.5M | 0.53% | 328,750 | – | – |
|
|
EPZM
65
DELISTED
Epizyme, Inc
EPZM
| $24.4M | 0.53% | 2,802,954 +249,746 | +10% | +$2.18M |
|
66
Kymera Therapeutics
KYMR
$2.95B
| $24.2M | 0.53% | 621,777 -92,088 | -13% | -$3.58M |
|
67
NovoCure
NVCR
$1.38B
| $23.1M | 0.5% | 175,000 | – | – |
|
|
XENT
68
DELISTED
Intersect ENT, Inc
XENT
| $22.6M | 0.49% | 1,080,200 +380,200 | +54% | +$7.94M |
|
69
Collegium Pharmaceutical
COLL
$1.22B
| $21.8M | 0.48% | 920,000 -180,000 | -16% | -$4.27M |
|
70
Inspire Medical Systems
INSP
$2.77B
| $20.7M | 0.45% | 100,000 -113,350 | -53% | -$23.5M |
|
|
ABCM
71
DELISTED
Abcam plc American Depositary Shares
ABCM
| $20.6M | 0.45% | 1,069,236 +144,236 | +16% | +$2.77M |
|
|
OSH
72
DELISTED
Oak Street Health, Inc.
OSH
| $20.4M | 0.44% | 375,000 | – | – |
|
73
Kura Oncology
KURA
$686M
| $20.1M | 0.44% | 710,035 +201,919 | +40% | +$5.71M |
|
74
BioMarin Pharmaceuticals
BMRN
$11.2B
| $19.1M | 0.42% | 253,500 | – | – |
|
75
Rocket Pharmaceuticals
RCKT
$354M
| $17.9M | 0.39% | 403,070 +2,700 | +0.7% | +$120K |
|